Mitochondrial dysfunction linked to Alzheimer’s onset and treatment response

Changes in how brain cells generate energy may drive the development of Alzheimer’s disease and influence how patients respond to therapy, according to a new study from Mayo Clinic researchers. The findings, published in the journal Alzheimer’s & Dementia, spotlight mitochondrial complex I—a critical component of cellular energy production—as both a contributor to disease progression and a promising target for new treatments.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup